MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, NWBO made $200K in revenue. -$26,550K in net income. Net profit margin of -13275.00%.

Income Overview

Revenue
$200K
Net Income
-$26,550K
Net Profit Margin
-13275.00%
EPS
-$0.02
Unit: Thousand (K) dollars

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Research and other
200 131 375 82*
Research and development
7,450 7,430 8,351 9,124*
General and administrative
7,070 7,480 9,335 7,939*
Total operating costs and expenses
14,520 14,910 17,686 17,062*
Foreign currency transaction gain (loss)
-3,640 1,898 -6,863*
Loss from operations
-14,320 -14,779 -17,311 -16,980*
Change in fair value of derivative liabilities
-3,332 724 1,280 -864*
Loss from warrant modification
----205*
Change in fair value of share payable
-118 -240 -23 -189*
Change in fair value of convertible notes
-15 2,392 3,697 3,446*
Loss from extinguishment of debt
-4,004 -4,516 -7,282 -2,792*
Loss from issuance of debt
-1,611 -773 --209*
Interest expense
2,621 1,826 1,602 2,126*
Foreign currency transaction gain (loss)
-808 ---
Total other expense
-12,509 -599 -2,032 -9,803*
Net loss
-26,829 -15,378 -19,343 -26,783*
Deemed dividend related to warrant modifications
353 560 265 555*
Net loss attributable to common stockholders
-27,182 -15,938 -19,608 -27,338*
Foreign currency translation adjustment
-632 3,248 1,644 -377*
Total comprehensive loss
-26,550 -19,186 -21,252 -26,961
Basic EPS
-0.02 -0.01 -0.01 -21.502
Diluted EPS
-0.02 -0.01 -0.01 -21.502
Basic Average Shares
1,492,079 1,438,198 1,359,496 1,253,863
Diluted Average Shares
1,492,079 1,438,198 1,359,496 1,253,863
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$26,550K Foreign currencytranslation adjustment-$632K Net lossattributable to common...-$27,182K (-39.35%↓ Y/Y)Net loss-$26,829K (-38.48%↓ Y/Y)Deemed dividendrelated to warrant...$353K (167.42%↑ Y/Y)Loss from operations-$14,320K (3.25%↑ Y/Y)Total other expense-$12,509K (-173.54%↓ Y/Y)Research and other$200K (-43.98%↓ Y/Y)Total operating costsand expenses$14,520K (-4.21%↓ Y/Y)Loss fromextinguishment of debt-$4,004K (41.29%↑ Y/Y)Change in fair value ofderivative liabilities-$3,332K (-109.56%↓ Y/Y)Interest expense$2,621K (26.01%↑ Y/Y)Loss from issuance ofdebt-$1,611K Foreign currencytransaction gain (loss)-$808K Change in fair value ofshare payable-$118K (-268.57%↓ Y/Y)Change in fair value ofconvertible notes-$15K (-100.49%↓ Y/Y)Research and development$7,450K (-8.36%↓ Y/Y)General andadministrative$7,070K (0.60%↑ Y/Y)

NORTHWEST BIOTHERAPEUTICS INC (NWBO)

NORTHWEST BIOTHERAPEUTICS INC (NWBO)